Cell Therapeutics Signs Financing Agreement

Cell Therapeutics (CTIC) has entered a financing agreement with Societe Generale Group for the French bank to buy $55M new shares to trade on the Italian stock exchange.

Societe Generale Group will have the option to purchase an additional $17M over the next 24 months.

CTIC is a biotechnology company that develops drugs to combat cancer and related conditions. It’s flagship product, XYOTAX, is undergoing trails for approval and sale.

Source: The Associated Press


Technorati Tags: , , , , , ,


Leave a Reply

Your email address will not be published. Required fields are marked *

Spam protection by WP Captcha-Free